Jun Yang, MD
Allergy · Tinton Falls, NJNPI 1730166414
Payments from drug & device makers
Across 515 payments — averaging $413.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$203K
- AstraZeneca$2K
- GSK$2K
- CSL Behring$831
- Optinose US, Inc.$624
- Sanofi$554
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $203,183 |
| AstraZeneca | 98 | $2,437 |
| GSK | 103 | $2,113 |
| CSL Behring | 44 | $831 |
| Optinose US, Inc. | 34 | $624 |
| Sanofi | 22 | $554 |
| Genentech USA, Inc. | 23 | $531 |
| Alk-abello, Inc | 18 | $395 |
| Pfizer | 22 | $333 |
| Regeneron Healthcare Solutions, Inc. | 20 | $315 |
| Novartis | 15 | $268 |
| Teva Pharmaceuticals USA, Inc. | 15 | $201 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $180 |
| Grifols USA, LLC | 11 | $172 |
| Kaleo, Inc. | 7 | $120 |
| Octapharma USA, Inc. | 4 | $85 |
| Amgen(2 entities) | 5 | $78 |
| Boehringer Ingelheim | 6 | $76 |
| Aimmune Therapeutics, Inc. | 5 | $70 |
| Bio Products Laboratory USA, Inc. | 3 | $67 |
| Biocryst US Sales Co., LLC | 4 | $61 |
| Greer Laboratories, Inc. | 3 | $60 |
| Incyte Corporation | 3 | $43 |
| Shire North American Group Inc | 3 | $39 |
| Circassia Inc. | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 2 | $29 |
| Merck | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| AbbVie | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Organon | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
How this compares
$213,045 in reported general payments places this provider in the 85th percentile of 35 allergy providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Tinton Falls
- John OppenheimerCedar Knolls$923K
- Jeffrey WeissRiverdale$836K
- Jay KashkinFair Lawn$486K
- Gregory TociMarlton$317K
- Shashank ShethVoorhees$127K
- Mathew VargheseNorth Bergen$93K
- Eugene GattiMarlton$43K
- Howard DruceSomerville$37K
- Donatella GraffinoCedar Knolls$15K
- Maria Lania-HowarthVoorhees$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.